Clinical effectiveness of branded versus generic piperacillin-tazobactam for treating severe community-acquired pneumonia

Clinical effectiveness of branded versus generic piperacillin-tazobactam for treating severe community-acquired pneumonia

Purpose: To compare the clinical effectiveness of branded versus generic piperacillin-tazobactam for treating severe community-acquired pneumonia (CAP). Patients and methods: We identified patients with severe CAP who received piperacillin-tazobactam based on a nine-center registry database. Further...

Full description

Bibliographic Details
Main Authors: Cheng-Yi Wang, Chia-Hung Chen, Chih-Yen Tu, Wei-Chih Chen, Li-Kuo Kuo, Yao-Tung Wang, Pin-Kuei Fu, Shih-Chi Ku, Wen-Feng Fang, Chin-Ming Chen, Chih-Cheng Lai
Format: Article
Language:English
Published: Elsevier 2022-09-01
Series:Journal of Infection and Public Health
Subjects:
Brand-name
Community-acquired pneumonia
Effectiveness
Generic name
Piperacillin-tazobactam
Online Access:http://www.sciencedirect.com/science/article/pii/S1876034122001861

Internet

http://www.sciencedirect.com/science/article/pii/S1876034122001861

Similar Items